Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
211MO Giredestrant (GDC-9545) vs physician choice of endocrine monotherapy (PCET) in patients (pts) with ER+, HER2– locally advanced/metastatic breast cancer (LA/mBC): Primary analysis of the phase II, randomised, open-label acelERA BC study
M. Martín Jiménez, Elgene Lim, M. Chavez Mac Gregor, Aditya Bardia, Jun Wu, Q. Zhang and 14 more
- Rank
- 74 of 3,616
- Percentile
- top 2.1%
- Where
- Annals of Oncology, 2022
- Citations
- 54
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.